SPP1 + Macrophage‐ POSTN + Fibroblast‐Endothelial Triad Dictates Immunotherapy Response in Bladder Cancer
The FASEB Journal · 28.02.2026 · 40 (4)
DOI: 10.1096/fj.202504456rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 07.02.2026. Verfasst von Hualin Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Immunotherapy, Cancer-Associated Fibroblasts, Osteopontin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: CAMS | Chinese Academy of Medical Sciences Initiative for Innovative Medicine (), national high level hospital clinical research funding, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Abstract (Originalsprache)
Although immunotherapy has shown promise in improving outcomes for bladder cancer (BCa) patients, treatment responses remain highly variable. A comparative examination of the tumor microenvironment (TME) between responders and non‐responders may reveal key resistance mechanisms and identify potential therapeutic targets. We integrated spatial transcriptomics, single‐cell RNA sequencing, and multiplexed immunofluorescence to characterize spatial structures within the TME that influence response to anti‐PD‐1 therapy in BCa patients. In non‐responders, we observed an accumulation of stem‐like malignant epithelial cells with high MYBL2 expression near the tumor boundary. Furthermore, we identified a spatial triad structure—composed of SPP1 + tumor‐associated macrophages (TAMs), POSTN + cancer‐associated fibroblasts (CAFs), and endothelial cells—located at the tumor periphery. This structure was associated with T‐cell exclusion and reduced efficacy of immune checkpoint blockade. In a preclinical model, inhibiting SPP1 enhanced the response to anti‐PD‐1 therapy, resulting in reduced CAF infiltration and increased recruitment of cytotoxic T cells. Our study reveals a triad cellular structure mediated by SPP1 + TAMs, POSTN + CAFs, and endothelial cells that contribute to immunotherapy resistance in BCa. Targeting this structure, particularly through SPP1 blockade, represents a promising strategy to augment the efficacy of immune checkpoint inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
- Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
ORCID-Profile: Zhigang Ji
Förderung
- CAMS | Chinese Academy of Medical Sciences Initiative for Innovative Medicine ()
- national high level hospital clinical research funding
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Chen, H., Peng, Y., Ji, Z., & Dong, J. (2026). SPP1 + Macrophage‐ POSTN + Fibroblast‐Endothelial Triad Dictates Immunotherapy Response in Bladder Cancer. The FASEB Journal, 40(4). https://doi.org/10.1096/fj.202504456rr
Vancouver
Chen H, Peng Y, Ji Z, Dong J. SPP1 + Macrophage‐ POSTN + Fibroblast‐Endothelial Triad Dictates Immunotherapy Response in Bladder Cancer. The FASEB Journal. 2026;40(4). doi:10.1096/fj.202504456rr
BibTeX
@article{Chen2026,
author = {Chen, Hualin and Peng, Yueqiang and Ji, Zhigang and Dong, Jie},
title = {SPP1 + Macrophage‐ POSTN + Fibroblast‐Endothelial Triad Dictates Immunotherapy Response in Bladder Cancer},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {4},
doi = {10.1096/fj.202504456rr}
}
EUVIMED